EUVIMEDEUVIMED entdecken
Qualitative Studie

What does it mean to be “healthy” when taking elexacaftor/tezacaftor/ivacaftor (ETI)? A qualitative study

Robin S Everhart, Emma McWilliams, Jill Maggs, Gregory S Sawicki, Takeera Sconiers, Kyle Smith, Dana Yablon, Jennifer Butcher, Michelle Prickett, Callie Bacon, Andrea Goodman, Alex H Gifford und 3 weitere

Journal of Cystic Fibrosis · 2025-01 · 24 (1) · 187-192

DOI: 10.1016/j.jcf.2024.11.003 ↗

Kurz gefasst

Qualitative Studie in der Zeitschrift Journal of Cystic Fibrosis, 2025-01. Verfasst von Robin S Everhart und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA. Electronic address: reverhart@vcu.edu. Hauptthemen laut MEDLINE: Cystic Fibrosis, Aminophenols, Benzodioxoles, Indoles. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: Cystic Fibrosis Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisAminophenolsBenzodioxolesIndolesQuinolonesPyridinesHumansMaleFemaleAdultQualitative ResearchDrug CombinationsMiddle AgedChloride Channel AgonistsAdolescentAgedQuality of LifePyrazolesQuinolines

Stichwörter der Autor:innen

HealthModulator TherapyQualitative

Substanzen

AminophenolsDrug CombinationsBenzodioxolesIndolesQuinolonesChloride Channel AgonistsPyridineselexacaftor, ivacaftor, tezacaftor drug combinationPyrazolesQuinolines

Autor:innen und Institutionen

  • Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA. Electronic address: reverhart@vcu.edu.
  • Division of Pulmonary Medicine, Boston Children's Hospital, Boston, MA, USA.
  • Community Member, former STRC Steering Committee Member, c/o Cystic Fibrosis Foundation, Bethesda, MD, USA.
  • Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, USA.
  • Department of Pediatrics, Division of Pediatric Psychology, Mott Children's Hospital, University of Michigan Health, Ann Arbor, MI, USA.
  • Division of Pulmonary and Critical Care, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Förderung

  • Cystic Fibrosis Foundation

Zitieren

APA

Everhart, R. S., McWilliams, E., Maggs, J., Sawicki, G. S., Sconiers, T., Smith, K., Yablon, D., Butcher, J., Prickett, M., Bacon, C., Goodman, A., Gifford, A. H., Mayer-Hamblett, N., Nichols, D. P., & Riekert, K. A. (2025). What does it mean to be “healthy” when taking elexacaftor/tezacaftor/ivacaftor (ETI)? A qualitative study. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2024.11.003

Vancouver

Everhart RS, McWilliams E, Maggs J, Sawicki GS, Sconiers T, Smith K, et al. What does it mean to be “healthy” when taking elexacaftor/tezacaftor/ivacaftor (ETI)? A qualitative study. Journal of Cystic Fibrosis. 2025. doi:10.1016/j.jcf.2024.11.003

BibTeX
@article{Everhart2025,
  author = {Everhart, Robin S and McWilliams, Emma and Maggs, Jill and Sawicki, Gregory S and Sconiers, Takeera and Smith, Kyle and Yablon, Dana and Butcher, Jennifer and Prickett, Michelle and Bacon, Callie and Goodman, Andrea and Gifford, Alex H and Mayer-Hamblett, Nicole and Nichols, David P and Riekert, Kristin A},
  title = {What does it mean to be “healthy” when taking elexacaftor/tezacaftor/ivacaftor (ETI)? A qualitative study},
  journal = {Journal of Cystic Fibrosis},
  year = {2025},
  doi = {10.1016/j.jcf.2024.11.003}
}
Kostenlos starten →